Q1 2023 Digital Health Report
Q1 2023 Digital Health Report unknown Fill out the form to download a preview of this report. The full report is available through the PitchBook Platform. Are we in the age of Ozempic?
Weight loss drugs such as Wegovy, Ozempic, and Mounjaro have exploded onto the digital health scene, and companies and investors are looking to cash in. But behind the glossy ads, the drugs come with potential side effects, patient risks, and high price tags.
Is this VC’s latest fad or a lasting transformation to healthcare? Our Q1 2023 Digital Health Report digs deep into this trend and others in a precarious time for an industry where exits have almost entirely come to a standstill. Table of contents
| Vertical update | 3 |
| Q1 2023 timeline | 4 |
| Digital health landscape | 5 |
| Digital health VC ecosystem market map | 6 |
| VC activity | 8 |
| Emerging opportunities | 14 |
| Weight loss management | 15 |
| Telehealth shift from DTC to B2B | 17 |
| Select company highlights | 19 |
| Monogram Health | 20 |
| Papa | 23 |
| Headspace Health | 26 |